Juraj Velcicky

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Juraj Velcicky, Matthias R Bauer, Achim Schlapbach, Guillaume Lapointe, Arndt Meyer, Markus Vögtle, Ernst Blum, Estelle Ngo, Catherine Rolando, Pierre Nimsgern, Sylvie Teixeira-Fouchard, Hansjoerg Lehmann, Pascal Furet, Frédéric Berst, Jens Schümann, Rowan Stringer, Patrice Larger, Cindy Schmid, Catriona T Prendergast, Simone Riek, Patrick Schmutz, Sylvie Lehmann, Jörg Berghausen, Clemens Scheufler, Jean-Michel Rondeau, Christoph Burkhart, Thomas Knoepfel, Nina Gommermann
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors. Journal of medicinal chemistry (2024)
Anna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, Jutta Blank, Ralf Boesch, Andreas Boettcher, Frédéric Bornancin, Sylvia Buhr, Lauren E Connor, Christoph E Dumelin, Oliver Esser, Michael Hediger, Samuel Hintermann, Ulrich Hommel, Elke Koch, Guillaume Lapointe, Lukas Leder, Sylvie Lehmann, Philipp Lehr, Peter Meier, Lionel Muller, Daniela Ostermeier, Paul Ramage, Sihame Schiebel-Haddad, Alexander Baxter Smith, Aleksandar Stojanovic, Juraj Velcicky, Rina Yamamoto, Konstanze Hurth
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches. Journal of medicinal chemistry (2024)
Juraj Velcicky, Philipp Janser, Nina Gommermann, Silke Brenneisen, Slavica Ilic, Eric Vangrevelinghe, Nikolaus Stiefl, Andreas Boettcher, Christelle Arnold, Claire Malinverni, Janet Dawson, Renata Murgasova, Sandrine Desrayaud, Karen Beltz, Alexandra Hinniger, Carien Dekker, Christopher J Farady, Angela Mackay
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors. Journal of medicinal chemistry (2024)
Juraj Velcicky, Philipp Janser, Nina Gommermann, Silke Brenneisen, Slavica Ilic, Eric Vangrevelinghe, Nikolaus Stiefl, Andreas Boettcher, Christelle Arnold, Claire Malinverni, Janet Dawson, Renata Murgasova, Sandrine Desrayaud, Karen Beltz, Alexandra Hinniger, Carien Dekker, Christopher J Farady, Angela Mackay
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors. Journal of medicinal chemistry 67 (2) (2024)
Anna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, Jutta Blank, Ralf Boesch, Andreas Boettcher, Frédéric Bornancin, Sylvia Buhr, Lauren E Connor, Christoph E Dumelin, Oliver Esser, Michael Hediger, Samuel Hintermann, Ulrich Hommel, Elke Koch, Guillaume Lapointe, Lukas Leder, Sylvie Lehmann, Philipp Lehr, Peter Meier, Lionel Muller, Daniela Ostermeier, Paul Ramage, Sihame Schiebel-Haddad, Alexander Baxter Smith, Aleksandar Stojanovic, Juraj Velcicky, Rina Yamamoto, Konstanze Hurth
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches. Journal of medicinal chemistry 67 (10) (2024)
Juraj Velcicky, Philipp Janser, Nina Gommermann, Silke Brenneisen, Slavica Ilic, Eric Vangrevelinghe, Nikolaus Stiefl, Andreas Boettcher, Christelle Arnold, Claire Malinverni, Janet Dawson, Renata Murgasova, Sandrine Desrayaud, Karen Beltz, Alexandra Hinniger, Carien Dekker, Christopher J Farady, Angela Mackay
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors. Journal of medicinal chemistry 67 (2) (2024)
Anna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, Jutta Blank, Ralf Boesch, Andreas Boettcher, Frédéric Bornancin, Sylvia Buhr, Lauren E Connor, Christoph E Dumelin, Oliver Esser, Michael Hediger, Samuel Hintermann, Ulrich Hommel, Elke Koch, Guillaume Lapointe, Lukas Leder, Sylvie Lehmann, Philipp Lehr, Peter Meier, Lionel Muller, Daniela Ostermeier, Paul Ramage, Sihame Schiebel-Haddad, Alexander Baxter Smith, Aleksandar Stojanovic, Juraj Velcicky, Rina Yamamoto, Konstanze Hurth
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches. Journal of medicinal chemistry 67 (10) (2024)
Juraj Velcicky, Rainer Wilcken, Simona Cotesta, Philipp Janser, Achim Schlapbach, Trixie Wagner, Philippe Piechon, Frederic Villard, Rochdi Bouhelal, Fabian Piller, Stephanie Harlfinger, Rowan Stringer, Dominique Fehlmann, Klemens Kaupmann, Amanda Littlewood-Evans, Matthias Haffke, Nina Gommermann
Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure. Journal of medicinal chemistry 63 (17) (2020)
Juraj Velcicky, Ursula Bodendorf, Pascal Rigollier, Robert Epple, Daniel R Beisner, Danilo Guerini, Philip Smith, Bo Liu, Roland Feifel, Peter Wipfli, Reiner Aichholz, Philippe Couttet, Ina Dix, Toni Widmer, Ben Wen, Trixi Brandl
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. Journal of medicinal chemistry 61 (3) (2018)
Juraj Velcicky, Wolfgang Miltz, Berndt Oberhauser, David Orain, Andrea Vaupel, Klaus Weigand, Janet Dawson King, Amanda Littlewood-Evans, Mark Nash, Roland Feifel, Pius Loetscher
Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and Angiogenesis. Journal of medicinal chemistry 60 (9) (2017)

Juraj Velcicky.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Juraj Velcicky